CORD-19:775b90287b44353bee979abb0970a4666022f86d / 762940-763148 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"Severity of attack symptoms at each affected anatomical location was assessed using a 100 mm visual analog scale (VAS) prior to treatment and at regular intervals following administration of study medication.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T86276","span":{"begin":0,"end":208},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T86276","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T290","span":{"begin":0,"end":208},"obj":"Sentence"}],"attributes":[{"subj":"T290","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1522","span":{"begin":107,"end":112},"obj":"Body_part"}],"attributes":[{"id":"A1522","pred":"uberon_id","subj":"T1522","obj":"http://purl.obolibrary.org/obo/UBERON_0002542"},{"subj":"T1522","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#d293ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93ecb8"},{"id":"CORD-19-PD-UBERON","color":"#ec9e93"}]}]}}